CRP and Rare hereditary thrombophilia: Further systemic evaluations, including tests for antinuclear antibodies, antineutrophil cytoplasmic antibodies (ANCAs), blood viscosity, antiphospholipid syndrome, coagulation function, complete blood count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), angiotensin-converting enzyme inhibitors (ACEIs), TORCH panel, thromboelastogram (TEG), transthoracic echocardiography (TTE), lower limb venous ultrasound, carotid ultrasound, brain magnetic resonance imaging (MRI), and thrombophilia gene screening, yielded no significant findings.